| Literature DB >> 36010500 |
Hao Deng1,2, Yujie Feng3, Guang Wu1,2, Ronghu Zhang1, Bei Li4, Qingchun Yin4, Lin Luo5.
Abstract
Recently, there have been increasing safety concerns about the illegal abuse of quinolone in soybean sprouts. This study aimed to establish an ultra-high performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) method for the simultaneous detection of 16 quinolones (QNs) in soybean sprouts, and then reveal their degradation characteristics. The samples were extracted with acetonitrile (with 1% formic acid), purified by a C18 adsorbent, and separated by an ACQUITY UPLC BEH C18 (1.7 μm, 2.1 mm × 100 mm) column. The internal standard method was applied for quantitative determination. The results demonstrated that the quantification linear range for 16 QNs was between 2.0 ng/mL and 50.0 ng/mL. The detection limits were between 0.5 μg/kg and 4.0 μg/kg, and the quantification limits were between 2.0 μg/kg and 20.0 μg/kg. This method was used to screen for quinolones in 50 batches of market soybean sprouts; the obtained results showed good agreement with those of the standard method. It was found that QNs possessed longer degradation half-life (T1/2) in the storage stage of soybean sprouts, while they degraded to some extent during the germination stage via active enzyme action. In particular, ciprofloxacin was the most stable QNs with a T1/2 of 70.71 d during the storage stage of soybean sprouts. This work not only offers an accurate and efficient QNs residual analysis strategy but also provides a reference for the supervision and management of QNs in foods.Entities:
Keywords: UPLC-MS/MS; degradation; detection; quinolones; soybean sprout
Year: 2022 PMID: 36010500 PMCID: PMC9407237 DOI: 10.3390/foods11162500
Source DB: PubMed Journal: Foods ISSN: 2304-8158
Figure 1Preparation, purification, UPLC-MS/MS detection of 16 quinolones.
Linear equation, limits of detection and quantification, precision of 16 quinolones.
| Compound | Linear Equation | R2 | Limit of | Limits of Quantification/(μg/kg) | RSD/% ( |
|---|---|---|---|---|---|
| Enrofloxacin | y = 1.08828x + 0.01962 | 0.99958 | 4.0 | 8.0 | 4.3 |
| Ciprofloxacin | y = 1.54110x + 0.09348 | 0.99849 | 2.0 | 8.0 | 2.2 |
| Ofloxacin | y = 0.96849x + 0.04587 | 0.99901 | 4.0 | 8.0 | 2.3 |
| Norfloxacin | y = 1.39138x − 0.03124 | 0.99947 | 3.0 | 8.0 | 7.1 |
| Pefloxacin | y = 0.67444x + 0.03205 | 0.99875 | 1.0 | 8.0 | 5.2 |
| Lomefloxacin | y = 4.53358x − 0.05440 | 0.99956 | 4.0 | 20.0 | 6.0 |
| Dalfloxacin | y = 4.07682x + 0.00796 | 0.99870 | 3.0 | 4.0 | 4.3 |
| Sarafloxacin | y = 1.00208x − 0.00294 | 0.99938 | 1.0 | 20.0 | 6.4 |
| Flurofloxacin | y = 0.93473x + 0.10372 | 0.99912 | 2.0 | 20.0 | 7.9 |
| Difluoxacin | y = 1.24093x + 0.04245 | 0.99926 | 3.0 | 20.0 | 6.5 |
| Sparfloxacin | y = 1.58249x − 0.04456 | 0.99922 | 1.0 | 8.0 | 5.6 |
| Enoxacin | y = 1.76071x − 0.00857 | 0.99943 | 2.0 | 20.0 | 5.9 |
| Nalidixic acid | y = 71.34290x + 1.22451 | 0.99905 | 0.5 | 2.0 | 2.3 |
| Oxalic acid | y = 70.85536x − 1.20356 | 0.99951 | 1.0 | 2.0 | 2.8 |
| Flumequine | y = 74.88015x − 0.62798 | 0.99923 | 1.0 | 2.0 | 1.6 |
| Orbifloxacin | y = 1.30092x + 0.13993 | 0.99910 | 1.0 | 8.0 | 7.4 |
Comparison and verification of the two analysis methods.
| Compound | UPLC-MS/MS Method | UPLC-MS/MS Method of BJS 201909 (ug/kg) | Number of Positive Samples |
|---|---|---|---|
| Enrofloxacin | 30.5 ± 0.2 | 31.7 ± 0.3 | 1 |
| Ciprofloxacin | 120.0 ± 0.8 | 124.1 ± 0.8 | 1 |
| Norfloxacin | 33.9 ± 0.1 | 35.1 ± 0.2 | 1 |
Degradation characterization of 16 QNs in production and storage stage of soybean sprout.
| Compound | Production Stage | Degradation Equation | R2 | T1/2 | Storage Stage | Degradation Equation | R2 | T1/2 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 d | 2 d | 3 d | 4 d | 5 d | 6 d | 7 d | 8 d | 9 d | 10 d | |||||||
| Orbifloxacin | 21.6 | 20.5 | 20.2 | 19.6 | 17.8 | C = 22.5950 × e−0.0423t | 0.9143 | 16.38 | 16.7 | 16.6 | 16.4 | 15.6 | 15.3 | C = 17.2841 × e−0.0234t | 0.9035 | 29.62 |
| Fleroxacin | 20.9 | 17.8 | 17.9 | 17.9 | 16.1 | C = 21.193 × e−0.0532t | 0.7618 | 13.03 | 12.8 | 12.9 | 12.4 | 10.9 | 10.3 | C = 14.0585 × e−0.0578t | 0.8546 | 11.99 |
| Lomefloxacin | 20.9 | 19.6 | 17.7 | 17.1 | 16.0 | C = 22.2827 × e−0.0679t | 0.9816 | 10.21 | 13.0 | 12.6 | 12.2 | 11.5 | 11.2 | C = 13.573 × e−0.0388t | 0.9848 | 17.86 |
| Norfloxacin | 20.8 | 19.3 | 18.3 | 18.1 | 13.7 | C = 22.9867 × e−0.083t | 0.8196 | 8.35 | 12.8 | 12.6 | 11.5 | 10.7 | 10.4 | C = 13.7478 × e−0.0577t | 0.9546 | 12.01 |
| Enrofloxacin | 20.4 | 17.9 | 17.0 | 15.9 | 14.2 | C = 21.8759 × e−0.0849t | 0.9755 | 8.16 | 12.2 | 11.9 | 11.5 | 10.9 | 9.9 | C = 13.0324 × e−0.0489t | 0.9284 | 14.17 |
| Enoxacin | 21.5 | 20.3 | 19.2 | 16.9 | 14.8 | C = 24.0252 × e−0.089t | 0.956 | 7.79 | 13.8 | 13.4 | 12.6 | 11.4 | 10.8 | C = 14.9644 × e−0.064t | 0.9678 | 10.83 |
| Ofloxacin | 21.7 | 16.5 | 16.3 | 16.2 | 14.4 | C = 22.1889 × e−0.0913t | 0.7644 | 7.59 | 13.4 | 12.8 | 12.1 | 10.7 | 10.7 | C = 14.3661 × e−0.063t | 0.9443 | 11.00 |
| Pefloxacin | 21.3 | 20.9 | 17.8 | 17.3 | 13.6 | C = 24.4381 × e−0.102t | 0.9019 | 6.79 | 13.4 | 12.5 | 10.3 | 10.0 | 10.0 | C = 14.4115 × e−0.0853t | 0.8731 | 8.12 |
| Difloxacin | 20.8 | 18.2 | 16.8 | 15.9 | 13.1 | C = 22.9377 × e−0.1042t | 0.9666 | 6.65 | 10.0 | 9.9 | 9.4 | 9.1 | 9.1 | C = 10.3084 × e−0.0275t | 0.9171 | 25.20 |
| Sarafloxacin | 19.9 | 17.0 | 16.0 | 15.1 | 11.6 | C = 22.2009 × e−0.1152t | 0.932 | 6.02 | 9.5 | 9.3 | 8.6 | 8.4 | 7.9 | C = 10.0362 × e−0.0468t | 0.9687 | 14.81 |
| Ciprofloxacin | 19.5 | 19.6 | 16.1 | 13.5 | 12.8 | C = 22.9318 × e−0.1184t | 0.9117 | 5.85 | 11.6 | 11.3 | 11.3 | 11.2 | 11.1 | C = 11.6347 × e−0.0098t | 0.8666 | 70.71 |
| Danofloxacin | 24.5 | 23.8 | 19.7 | 16.4 | 15.8 | C = 28.5983 × e−0.1236t | 0.9391 | 5.61 | 15.6 | 15.5 | 15.2 | 14.9 | 14.9 | C = 15.830 × e−0.0132t | 0.9357 | 52.50 |
| Sparfloxacin | 21.5 | 15.5 | 11.5 | 9.8 | 9.6 | C = 26.205 × e−0.2392t | 0.9421 | 2.90 | 8.5 | 8.3 | 8.2 | 8.1 | 7.7 | C = 8.7112 × e−0.022t | 0.9159 | 31.50 |
| Flumequine | 21.0 | 19.1 | 7.7 | 4.8 | 2.5 | C = 35.8092 × e−0.4513t | 0.8978 | 1.54 | 1.9 | 1.8 | 1.5 | 1.4 | 1.0 | C = 2.272 × e−0.1403t | 0.9223 | 4.94 |
| Oxalic acid | 18.9 | 16.4 | 8.5 | 4.2 | 1.1 | C = 32.187 × e−0.4521t | 0.9143 | 1.50 | 1.1 | 1.1 | 1.0 | 1.3 | 1.4 | C = 0.9477 × e0.0713t | 0.6231 | ---- |
| Nalidixic acid | 19.5 | 11.9 | 3.5 | 1.4 | 0.6 | C = 41.3012 × e−0.7202t | 0.9714 | 0.96 | 0.2 | 0.2 | 0.2 | 0.0 | 0.0 | C = 0.3474 × e−0.3877t | 0.6007 | 1.79 |
Note: according to the degradation equation and corresponding parameters simulated by the first-order kinetic model C = C0 × e-kt (C is the concentration on day t, μg/kg; C0 is the initial concentration, μg/kg; t is the time, d; k is the degradation rate constant). The half-lives of quinolones are expressed as T1/2 (At this time, C = 1/2 C0, T1/2 = ln2·k−1 = 0.693·k−1). ---- means no T1/2.